Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Variants in the GLP1R gene (such as rs6923761) and FTO gene (rs9939609) may alter receptor sensitivity and gastrointestinal hormone signaling, potentially affecting the intensity of nausea or indigestion during treatment initiation
Quick Stats for Pet Cognitive Supplement Market Pet Cognitive Supplement Market Value (2025): USD 850.0 million Pet Cognitive Supplement Market Forecast Value (2035): USD 1,472.5 million Pet Cognitive Supplement Market CAGR: 5.6% Leading Segment by Pet Type (2025): Dogs (72.0%) Leading Segment by Ingredient Type (2025): Omega-3 Fatty Acids (28.0%) Leading Segment by Form (2025): Chewables (55.0%) Key Growth Regions: South Asia & Pacific, Europe, and East Asia Top Companies by Market Share: Nestl Purina PetCare, Mars Petcare, Vetoquinol Pet Cognitive Supplement Market Key Takeaways Pet type segmentation reinforces these performance priorities: dogs hold ~72% share due to superior research validation and behavioral assessment capabilities, while cats at ~26% offer specialized neurological requirements in applications requiring feline-specific cognitive support within complex veterinary environments
A 32 mg pen delivers four weeks of 8 mg/week dosing
The peptide also reduces inflammation, easing discomfort and helping patients regain movement faster
US$ 27.34
US$ 25.64
US$ 21.86
US$ 20.93
US$ 20.20
